drugset / Trial / NCT00150735
Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy
Non-randomizedParallel-groupDouble-blind
Summary
A double-blind trial comparing the efficacy and safety of levetiracetam to carbamazepine used as monotherapy in subjects (≥ 16 years) newly or recently diagnosed as suffering from epilepsy, and experiencing partial or generalized tonic-clonic seizures.
Timeline
- Start
- 2002-06
- Primary completion
- 2005-07
- Completion
- 2005-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levetiracetam | Other / unclassified | 1000 mg | Oral |
| Subject | Levetiracetam | Other / unclassified | 3000 mg | Oral |